PetMed Express appoints Tamar Elkeles as independent director, board increases to 5
PetMed Express appointed Tamar Elkeles, Ph.D., as an independent director effective September 17, 2026, increasing the board from 4 to 5 members. The company said the appointment follows its recent CEO transition and is part of board refresh and governance efforts; the filing reports no financial results or guidance.
Key points
- Board appointment effective September 17, 2026; board size increased to 5 directors
- Dr. Elkeles, age 57, will serve until the 2027 annual meeting; the board determined she is independent under Nasdaq listing standards
- Appointed to the Compensation and Human Capital Committee and Corporate Governance and Nominating Committee; the press release describes her as Chair of the Compensation and Human Capital Committee
- Press release dated September 21, 2026 is furnished as Exhibit 99.1 under Item 7.01
The filing
Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 21, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.